CDD Wins $120,000 Prize in Competitive NCATS ASPIRE Challenge #2
Biotech-in-a-Box, CDD’s Solution for Combating the Opioid Crisis
Burlingame, California — April 24, 2021 — Collaborative Drug Discovery, Inc. (CDD) won $120,000 in the 2nd competitive stage of an NCATS ASPIRE Challenge hosted by the National Institutes of Health. In Oct 2019, CDD won $100,000 in the 1st competitive stage. For this challenge CDD designed a unique screening program that NCATS can use in its own facilities and pass on to others for combating the opioid crisis, accelerating the identification of less addictive and safer analgesics.
CDD’s solution is a “biotech-in-a-box” approach which offers the ability to maintain a highly customizable analgesics screening program using industry standard assays, FAIR and commercial quality informatics methods, state-of-the-art deep learning models, and agile strategies that are applicable to the current opioids crisis and beyond into other health areas. Four challenge components are included: 1. chemistry database, 2. synthetic chemistry ELN, 3. AI/predictive algorithms, and 4. biological assays.
The official announcement mentioning CDD with collaborators Christopher Lipinski and Lawrence Callahan (FDA), along with the other prize winners is available on this NIH web page.
About Collaborative Drug Discovery, Inc.
CDD’s (www.collaborativedrug.com) flagship product, “CDD Vault®”, is used to manage chemical registration, structure-activity relationships (SAR), and securely scale collaborations. CDD Vault® is a hosted database solution for secure management and sharing of biological and chemical data. It lets you intuitively organize chemical structures and biological study data, and collaborate with internal or external partners through an easy to use web interface. Available modules within CDD Vault include Activity & Registration, Visualization, Inventory, and ELN.
A complete list of more than 60 publications and patents from CDD can be found online on our resources page at https://www.collaborativedrug.com/publications-and-resources/.
Media Contact: Barry Bunin, Ph.D., Collaborative Drug Discovery, [email protected]